Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 28 Feb 2025

Dehydrodiisoeugenol targets the PLK1-p53 axis to inhibit breast cancer cell cycle

in Pharmacology of Anti-Cancer Drugs

Lin Li
Yifan Zheng
Yongxia Yang
Senlin Shi
Shangjie Liu
Keying Huang
Luonan Qiu
Rongxin Zhang
Wenbin Huang
Yin Leng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545498

1,692 views
1 citation

Mini Review

Published on 28 Feb 2025

Research progress on ferroptosis in Myelodysplastic syndromes

in Pharmacology of Anti-Cancer Drugs

Yifan Yang
Jiongping Han
Yuxin Wei
Jiacheng Jin
Weiyin Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561072

1,754 views

Original Research

Published on 28 Feb 2025

Repurposing hydrochlorothiazide (HCTZ) for colorectal cancer: a retrospective and single center study

in Pharmacology of Anti-Cancer Drugs

Dominic Chi-Chung Foo
Jiaxi Li
Zheng Huang
Siming Sui
Ryan Wai-Yan Sin
Abraham Tak Ka Man
Wai-Lun Law
Lui Ng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1449062

942 views

Original Research

Published on 26 Feb 2025

Small molecule inhibition of ubiquitin C-terminal hydrolase L1 alters cell metabolism proteins and exerts anti- or pro-tumorigenic effects contingent upon chemosensitivity status in high grade serous ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Corinne Jansen
Julia McAdams
Chloe Kim
Payton De La Cruz
Angelica Salaverria
Nicholas A. DaSilva
Kathryn Grive
Nicole E. James

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547164

1,255 views

Review

Published on 26 Feb 2025

Unleashing the power of peptides in prostate cancer immunotherapy: mechanism, facts and perspectives

in Pharmacology of Anti-Cancer Drugs

Xiaoya Li
Fang Yang
Meijing Wang
Xiaopeng Huang
Xin Zeng
Lu Zhou
Sixue Peng
Jingyi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1478331

4,357 views

Original Research

Published on 26 Feb 2025

Signal mining and analysis of ripretinib adverse events: a real-world pharmacovigilance analysis based on the FAERS database

in Pharmacology of Anti-Cancer Drugs

Ye Hu
Linlin Zhang
Qineng Gong
Lei Huang
Cunlin Yin
Yang Miao
Hui Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1481114

2,958 views

Review

Published on 26 Feb 2025

Mitochondria-associated non-coding RNAs and their impact on drug resistance

in Pharmacology of Anti-Cancer Drugs

Xingna An
Lina Sun
Huan Zheng
Yinghui Xiao
Weixia Sun
Dehai Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1472804

1,699 views
1 citation

Original Research

Published on 25 Feb 2025

Fenvalerate exposure induces AKT/AMPK-dependent alterations in glucose metabolism in hepatoma cells

in Pharmacology of Anti-Cancer Drugs

Lu Sun
Zheng-Guo Cui
Qianwen Feng
Jibran Sualeh Muhammad
Yu-Jie Jin
Songji Zhao
Lingqi Zhou
Cheng-AI Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540567

1,634 views

Review

Published on 24 Feb 2025

Asiatic acid in anticancer effects: emerging roles and mechanisms

in Pharmacology of Anti-Cancer Drugs

Rong Chen
Wan Zhang
Meizhi Zhang
Weidong Liu
Weike Feng
Yanan Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545654

1,466 views

Original Research

Published on 24 Feb 2025

Cepharanthine hydrochloride: a novel ferroptosis-inducing agent for prostate cancer treatment

in Pharmacology of Anti-Cancer Drugs

Jing-Song Guan
Jing Jia
Ze-Xiu Huang
Yu-Qing Zhou
Jing-Jie Zheng
Qi-Man Lin
Yi-Fei Wang
Jiang-Lin Fan
Yao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1536375

2,289 views
1 citation

Original Research

Published on 24 Feb 2025

Gold complex QB1561 suppresses drug-resistant cancer cells by inhibiting TrxR and mitochondrial respiratory function

in Pharmacology of Anti-Cancer Drugs

Hai-Ling Gao
Wenwen Ding
Zhi-Xin Shen
Qingbin Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1560880

1,953 views

Review

Published on 21 Feb 2025

A narrative review on diagnosis and treatment of ifosfamide-induced encephalopathy, the perspective of a EURACAN reference center for sarcomas

in Pharmacology of Anti-Cancer Drugs

A. Torchia
S. Vari
C. E. Onesti
S. Ceddia
M. Maschio
G. Maggi
F. Riva
W. Faltyn
M. Russillo
V. Ferraresi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1512966

2,759 views

Mini Review

Published on 21 Feb 2025

Antibody-drug conjugate combinations in cancer treatment: clinical efficacy and clinical study perspectives

in Pharmacology of Anti-Cancer Drugs

Xianglong Shi
Kai Tang
Quanbin Zhang
Qingkun Han
Lin Quan
Yijing Li
Jianqiao Cui
Nuan Feng
Jianbao Gong
Baoxin Shang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1556245

4,597 views
2 citations

Original Research

Published on 21 Feb 2025

Elucidation of Callistemon lanceolatus-derived natural compounds in STAT 3 pathway against human cancer cells: in silico and in vitro studies

in Pharmacology of Anti-Cancer Drugs

Mubashir Zafar
Sadaf Anwar
Malik Asif Hussain
Naveed Iqbal
Abrar Ali
Sadaf
Mohammad Zeeshan Najm
Mohd Adnan Kausar

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1507002

989 views

Original Research

Published on 21 Feb 2025

Adverse drug reactions to atezolizumab in combination with bevacizumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system database

in Pharmacology of Anti-Cancer Drugs

Wanming He
Lihua Tong
Yanling Yuan
Xia Yang
Wen Yang
Xingxi Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1448095

2,285 views

Review

Published on 20 Feb 2025

Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies

in Pharmacology of Anti-Cancer Drugs

Jun Wen
Aiwen Li
Ziliang Wang
Xiaoxiao Guo
Gaoling Zhang
Mark R. Litzow
Qiuju Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1536388

1,624 views